Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety Disorder
Status:
Withdrawn
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This research aims to investigate the efficacy and safety of buspirone in treating
generalized anxiety disorder with depressive symptoms and to evaluate its neuroprotective
effects using magnetic resonance imaging.